Oxford Nanopore Technologies (LON:ONT) Shares Down 8.7% – Should You Sell?

Oxford Nanopore Technologies plc (LON:ONT)’s share price was down 8.7% on Friday . The stock traded as low as GBX 104 and last traded at GBX 104.50. Approximately 2,707,194 shares traded hands during trading, a decline of 74% from the average daily volume of 10,334,964 shares. The stock had previously closed at GBX 114.50.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on ONT shares. Royal Bank Of Canada dropped their price target on Oxford Nanopore Technologies from GBX 300 to GBX 225 and set an “outperform” rating for the company in a research report on Tuesday, March 24th. Deutsche Bank Aktiengesellschaft lifted their price objective on Oxford Nanopore Technologies from GBX 210 to GBX 225 and gave the company a “buy” rating in a research report on Thursday, January 22nd. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 250 price objective on shares of Oxford Nanopore Technologies in a research report on Thursday, January 22nd. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, Oxford Nanopore Technologies has an average rating of “Moderate Buy” and an average price target of GBX 218.60.

Oxford Nanopore Technologies Stock Performance

The firm has a market cap of £1.05 billion, a PE ratio of -7.19 and a beta of 0.88. The company has a debt-to-equity ratio of 8.96, a current ratio of 3.56 and a quick ratio of 6.01. The stock has a 50-day moving average price of GBX 125.77 and a 200 day moving average price of GBX 135.25.

Oxford Nanopore Technologies (LON:ONT) last announced its quarterly earnings data on Monday, March 2nd. The company reported GBX (15.10) EPS for the quarter. Oxford Nanopore Technologies had a negative net margin of 64.85% and a negative return on equity of 29.43%.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.